Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386333926> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W4386333926 endingPage "6564" @default.
- W4386333926 startingPage "6558" @default.
- W4386333926 abstract "The goal of 'Measles and Rubella Strategic Framework 2021-2030' is to make A world free from measles and rubella. To be a part of this journey, Human Biologicals Institute has developed Mebella™ vaccine, which is a lyophilized Measles and Rubella (Live) vaccine. A randomized, single blind, comparative, multicenter Phase II/III trial was conducted to compare the immunogenicity and safety of Mebella™ vaccine with MR-VAC® vaccine in healthy subjects.A total of 888 subjects were enrolled in four age groups (222 subjects in each group) of 18 years to 49 years; 2 years to below 18 years; 12 months to below 24 months; and 9 months to below 12 months of age. The subjects were randomized in 2:1 ratio to receive single dose of either Mebella™ vaccine of Human Biologicals Institute or MR-VAC® vaccine. Immunogenicity was assessed at 42 days after the vaccination and was compared between the vaccine arms in each group. Safety was also assessed and compared between the vaccine arms during the study period.A total of 875 subjects completed the study out of 888 enrolled subjects. The seroprotection rates, seroconversion rates, and geometric mean titres for both Measles and Rubella components of Mebella™ vaccine were found to be comparable and non-inferior to the MR-VAC® vaccine after 42 days of vaccination. Injection site pain was the most common local adverse event reported whereas fever was the only systemic adverse event reported in both the vaccine arms. No serious adverse event was reported.It was concluded from the study results that the test vaccine, Mebella™, was immunogenic and well tolerated and was non-inferior to the comparator vaccine, MR-VAC®, when administered to healthy subjects of 9 months to 49 years of age. Clinical Trial Registry of India Identifier: CTRI/2020/07/026930." @default.
- W4386333926 created "2023-09-01" @default.
- W4386333926 creator A5027611941 @default.
- W4386333926 creator A5036390598 @default.
- W4386333926 creator A5040850769 @default.
- W4386333926 creator A5050975274 @default.
- W4386333926 creator A5059112906 @default.
- W4386333926 creator A5059241704 @default.
- W4386333926 creator A5062700058 @default.
- W4386333926 creator A5072969392 @default.
- W4386333926 creator A5074154935 @default.
- W4386333926 creator A5088089340 @default.
- W4386333926 creator A5090821828 @default.
- W4386333926 creator A5092725867 @default.
- W4386333926 date "2023-10-01" @default.
- W4386333926 modified "2023-10-15" @default.
- W4386333926 title "Immunogenicity and safety of Mebella™ vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority study" @default.
- W4386333926 cites W2038517759 @default.
- W4386333926 cites W2041232553 @default.
- W4386333926 cites W2044019867 @default.
- W4386333926 cites W2068813679 @default.
- W4386333926 cites W2096868235 @default.
- W4386333926 cites W2099213424 @default.
- W4386333926 cites W2162528068 @default.
- W4386333926 cites W2901058136 @default.
- W4386333926 cites W2911428886 @default.
- W4386333926 cites W3100994248 @default.
- W4386333926 cites W3167348971 @default.
- W4386333926 cites W3199805592 @default.
- W4386333926 cites W4292513001 @default.
- W4386333926 doi "https://doi.org/10.1016/j.vaccine.2023.08.065" @default.
- W4386333926 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37659893" @default.
- W4386333926 hasPublicationYear "2023" @default.
- W4386333926 type Work @default.
- W4386333926 citedByCount "0" @default.
- W4386333926 crossrefType "journal-article" @default.
- W4386333926 hasAuthorship W4386333926A5027611941 @default.
- W4386333926 hasAuthorship W4386333926A5036390598 @default.
- W4386333926 hasAuthorship W4386333926A5040850769 @default.
- W4386333926 hasAuthorship W4386333926A5050975274 @default.
- W4386333926 hasAuthorship W4386333926A5059112906 @default.
- W4386333926 hasAuthorship W4386333926A5059241704 @default.
- W4386333926 hasAuthorship W4386333926A5062700058 @default.
- W4386333926 hasAuthorship W4386333926A5072969392 @default.
- W4386333926 hasAuthorship W4386333926A5074154935 @default.
- W4386333926 hasAuthorship W4386333926A5088089340 @default.
- W4386333926 hasAuthorship W4386333926A5090821828 @default.
- W4386333926 hasAuthorship W4386333926A5092725867 @default.
- W4386333926 hasConcept C126322002 @default.
- W4386333926 hasConcept C159654299 @default.
- W4386333926 hasConcept C168563851 @default.
- W4386333926 hasConcept C187212893 @default.
- W4386333926 hasConcept C197934379 @default.
- W4386333926 hasConcept C203014093 @default.
- W4386333926 hasConcept C22070199 @default.
- W4386333926 hasConcept C2776438120 @default.
- W4386333926 hasConcept C2777451964 @default.
- W4386333926 hasConcept C2778814567 @default.
- W4386333926 hasConcept C2779185075 @default.
- W4386333926 hasConcept C2780657872 @default.
- W4386333926 hasConcept C2780868878 @default.
- W4386333926 hasConcept C2909545207 @default.
- W4386333926 hasConcept C71924100 @default.
- W4386333926 hasConceptScore W4386333926C126322002 @default.
- W4386333926 hasConceptScore W4386333926C159654299 @default.
- W4386333926 hasConceptScore W4386333926C168563851 @default.
- W4386333926 hasConceptScore W4386333926C187212893 @default.
- W4386333926 hasConceptScore W4386333926C197934379 @default.
- W4386333926 hasConceptScore W4386333926C203014093 @default.
- W4386333926 hasConceptScore W4386333926C22070199 @default.
- W4386333926 hasConceptScore W4386333926C2776438120 @default.
- W4386333926 hasConceptScore W4386333926C2777451964 @default.
- W4386333926 hasConceptScore W4386333926C2778814567 @default.
- W4386333926 hasConceptScore W4386333926C2779185075 @default.
- W4386333926 hasConceptScore W4386333926C2780657872 @default.
- W4386333926 hasConceptScore W4386333926C2780868878 @default.
- W4386333926 hasConceptScore W4386333926C2909545207 @default.
- W4386333926 hasConceptScore W4386333926C71924100 @default.
- W4386333926 hasIssue "44" @default.
- W4386333926 hasLocation W43863339261 @default.
- W4386333926 hasLocation W43863339262 @default.
- W4386333926 hasOpenAccess W4386333926 @default.
- W4386333926 hasPrimaryLocation W43863339261 @default.
- W4386333926 hasRelatedWork W2100795008 @default.
- W4386333926 hasRelatedWork W2154132887 @default.
- W4386333926 hasRelatedWork W216826928 @default.
- W4386333926 hasRelatedWork W2170033989 @default.
- W4386333926 hasRelatedWork W2415738339 @default.
- W4386333926 hasRelatedWork W2475007484 @default.
- W4386333926 hasRelatedWork W2773932566 @default.
- W4386333926 hasRelatedWork W3108486494 @default.
- W4386333926 hasRelatedWork W3126271444 @default.
- W4386333926 hasRelatedWork W4249616013 @default.
- W4386333926 hasVolume "41" @default.
- W4386333926 isParatext "false" @default.
- W4386333926 isRetracted "false" @default.
- W4386333926 workType "article" @default.